Finance News – Bristol Myers Squibb
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Ceo
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Bse
Etf
Eth
Stablecoin
Investment
Blockchain
Ipo
Index
Earnings
Solana
Revenue
Sec
Trade
Inflation
Interest Rates
Sensex
Token
Wall Street
Coinbase
Treasury
Nasdaq
Federal Reserve
Nse
Traders
Bse Sensex
China
Nifty
Sp 500
Profit
Tesla
Gold
Investor
Company
Defi
Market Conditions
Pfc
Sweat
22nd Century Group
Pi Token
Economic Deterrence
Home Testing Service
Tech Job Market
Wilmar International
One 97 Communications
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jul 23, 2025
Rheumatologists Eye AbbVieâs Rinvoq, Roche/Genentechâs Gazyva, and Bristol Myers Squibbâs Soty...
The increasing adoption of biologic therapies by U.S. rheumatologists to manage systemic lupus erythematosus indicates a growing market potential for companies developing innovativ...
Read Full Article →
Investopedia • Jun 02, 2025
BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration
The partnership between BioNTech and Bristol Myers Squibb has led to increased investor interest, resulting in a notable rise in BioNTech’s market value due to anticipated financia...
Read Full Article →